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The comparative analysis of primary and secondary structures, and hydropathy plots of hepatitis B virus (HBV) and hepatitis delta virus (HDV) 
proteins was carried out. Two short regions belonging to the HBV terminal protein were shown to be homologous to two regions; one encoded 
by HDV ORFS, and the other encoded by small ORF of the HDV antigenomic RNA strand. We propose a new protein containing both these 
regions may be synthesized in HDV infected cells. Stiking structural homology between the terminal protein of HBV and this predicted protein 
called HDAg’ of HDV may indicate a possible functional similarity.’ We hypothesize the HDAg’ may interact with and inhibit the polymerase 
activity of HBV. 
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1. INTRODUCTION 
Hepatitis delta virus (HDV) is a recently identified 
human pathogenic agent [I]. This virus is a defective 
naturally occurring satellite of human hepatitis B virus 
(HBV). The hepatitis delta virions are 36-nm particles 
with an envelope composed of hepatitis B surface an- 
tigen [ 11. The internal part of these particles consists of 
a HDV-specific protein, hepatitis delta antigen 
(HDAg), and a small genomic RNA [ 1,2]. The HDAg 
observed in the sera and liver of infected humans, or 
experimentally infected animals, has been shown to be 
composed of two protein species of between 24 and 
30 kDa [3,4], or a major 26 kDa protein and multiple 
minor proteins [5]. All of these proteins are related in 
sequence [4] and are encoded by the large open reading 
frame (ORF5) of the HDV antigenomic RNA [6,7]. No 
other HDV specific proteins have been detected. 
of Sciences of the USSR). The statistical significance of sequence 
alignment was evaluated according to Feng et al:[8]. The correlation 
coefficient (K) of hydropathy plots [9] was calculated by the method 
described in Sweet et al. [lo]. The method of Chow-Fasman was used 
for calculation of protein secondary structure [ll]. Sources of se- 
quences of HBV-specific proteins were taken from Miller 1121. HDV 
sequence information was obtained from published data [6,7,13,14]. 
3. RESULTS AND DISCUSSION 
The relationship between HDV and HBV suggests 
that HDV may use some unrecognized HBV-specific 
function(s) for its own replication despite the clear 
distinction in genetic organization of these viruses. We 
now report protein structure similarities of these viruses 
which suggests a possible functional interaction bet- 
ween HDV and HBV. 
Initially, we conducted a computer-assisted transla- 
tion of published HBV and HDV genomes. Terminator 
codons were considered as coding for amino acid X. 
The only strand of the HBV genome comprising the 
known ORFs for HBV proteins was translated in all 3 
phases. For HDV, both antigenomic and genomic 
strands were translated. Thus, the sequences of 3 HBV 
large polyproteins and 6 HDV polyproteins were ob- 
tained. Each of the HBV polyproteins were compared 
with all of the HDV polyproteins. Short regions of 10 
residues containing no less than 6 identical amino acids 
were chosen in comparing sequences. For the primary 
analysis of sequence similarity the subtype ayw HBV 
genome [14] and the HDV genome described by Wang 
et al. [7,13] were used. To define homologous regions 
more precisely other known sequences of HDV and 
HBV were analysed. 
2. MATERIALS AND METHODS 
The primary analysis of sequences was carried out with the use of 
matrix homology program DNASEQ (Institute of Protein, Academy 
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Two protein regions encoded by two segments of the 
HBV genome (2372-2461 and 2477-2542) have been 
identified as having amino acid sequence homology 
with two regions encoded by two segments of the HDV 
antigenomic strand (459-543 and 650-724). These two 
HBV protein regions were identified as two functional 
determinants in the N-terminal part of gene P product 
[15] which has been previously shown to function as a 
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GPYSGNPPBNKIKAPTLRPWVQ 
1 23 
Fig. 1. Comparison of region 1 and region 2 of HDAg’ with the N- 
terminal sequence of the gene P product of HBV and VPg of 
rhinovirus 14. Asterisks indicate identical residues in the comparing 
sequences. HDAg ’ , sequences of region 1 and 2 of the predicted 
frameshift polypeptide of HDV; POL HBV adw2, appropriate 
regions of the terminal protein of HBV subtype adw2; VPg rhino 14, 
the genome linked protein of rhinovirus 14. 
terminal protein [15-171. The first region encodes a 
negatively charged amphipathic a-helix. Such helices 
have been identified in the terminal proteins of 
adenoviruses and phi-29 phage just before a nucleic 
acid linkage site [ 181. Helices of this type have also been 
found to play a significant role in the interaction of 
some transcriptional factors with other proteins of the 
transcription apparatus. These protein helices contain 
determinants of protein interaction [19]. The second 
region has been demonstrated to be homologous to the 
VPg of picornaviruses [15]. Thus, two functionally 
essential regions of HBV gene P product are similar to 
two protein regions encoded by the HDV antigenomic 
RNA (Fig. 1). The percentage of coinciding amino 
acids in region 1 is 50% (P < lo-‘). The correlation 
coefficient (K) of hydropathy plots for the region of 
HBV and HDV polyproteins is 0.561 (P ~0.01). 
Region 2 has 46.2% identical residues (P < lo- ‘). The 
K value is 0.463 (P <0.02). Region 2 of HDV has 
significant similarity (39.1%; P c lo- 3, to the VPg of 
rhinovirus 14 (fig. 1). 
It is important to note that while the HBV regions 
belong to the same protein, the homologous regions of 
HDV are encoded by two different reading frames. 
Region 1 corresponds to the fragment 127-154 of 
HDAg and is encoded by ORFS. Region 2 is coded by 
a short ORF. The stop codons of the ORFS and the 
short ORF are separated by only one nucleotide (fig. 2). 
A frame shift mechanism or splicing event must occur 
to form a HDV protein encoded by both ORFS and the 
short ORF. We did not, however, find sequences 
resembling canonical splice sites; consequently, frame 
shifting seems to be a more plausible mechanism. Such 
a mechanism for protein synthesis is known to be wide- 
ly used in viral genome expression [20]. It has been 
shown that protein coding sequences can carry an addi- 
tional message in the form of a universal 3-base 
periodical pattern (G-nonG-N)m. At recognized slip- 
page sites the G-periodical pattern has been found to be 
interrupted. It reappears downstream from the slippage 
sites in a new frame [21]. We used this rule to find G- 
periodicity interrupted in the 0RF5 just at the border 
of the short ORF. The periodicity is restored in the 
short ORF (fig. 3). Thus, according to the G-perio- 
dicity rule the possible frame shifting site may be 
R 
GETGDFHGIYS 
EGLDIRGNRGFPWDILF 
GAGGGGCTGGACATCAGGGGAAACCGGGGATTTCCATGGGATATACTCTT 
631 
A ******* A 
*--_) - * 
SQPIRPFLPRVVDPSESTOP - HDAg’ 
PADPPFSPQSCRPQSTOP - HDAG 
CCCAGCCGATCCGCCCTTTTCTCCCCAGAGTTGTCGACCCCAGTGAAT~ 
- c-w - 
73; 
Fig. 2. Genetic organization of the region 631-730 of HDV antigenomic RNA strand. Sequences of the translation products of 0RF5 (HDAg) 
and small ORF (HDAg’) are shown over the line in single letter code. Symbol A under the line indicates two substitutions in HDV genome primary 
structure leading to the appearance of termination codon in these ORFs. Symbol R shown over the sequence of HDAg’ demonstrates substitution 
Gly for Arg in some protein sequences of the protein. Asterisks mark probable slippage site. Arrows indicate reverse repeats in RNA sequence. 
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Fig. 3. Distribution of guanines in the codons of ORF5 (dotted line) 
and small ORF (solid line). Arrow indicates position of probable 
ribosome frameshifting. 
located in a region coding for the segment 185-195 of 
HDAg. A stretch of four G residues is exactly placed 
within this region. Frameshifts are known to occur 
often in sites containing stretches of identical nucleo- 
tides [20]. Furthermore, the whole 3 ‘-terminal part of 
0RF5 is saturated with reverse repeats (fig. 2), which 
suggests the formation of a stable secondary structure 
within this mRNA region. Strong hairpin structures are 
also known to occur near frame shifting sites [20]. 
These data demonstrate the possibility for the syn- 
thesis of a new protein encoded by HDAg mRNA. This 
new protein designated HDAg ’ , may be synthesized by 
a translation slippage mechanism. The C-terminal part 
of the HDAg’ contains a new domain homologous to 
proposed DNA linkage site of the terminal protein of 
hepadnaviruses [ 151. In addition to primary structure 
homology we found significant similarities of the pro- 
tein secondary structure predicted by the method of 
Chow-Fasman (fig. 4). 
The striking structural similarities of the predicted 
new product of HDAg gene and the terminal protein of 
HBV suggest that they may share a common func- 
tion(s). The N-terminal part of the gene P product has 
been proposed to participate in priming of HBV DNA 
replication [ 15- 171. However, fundamental differences 
in genome organization and in the mechanism of 
genome replication of these two viruses suggests that 
HDAg’ priming for HDV RNA synthesis is unlikely. 
Nonetheless, the possibility of HBV polymerase in- 
teraction with HDAg’, like the terminal protein of 
HBV, cannot be excluded. Region 2 of HDAg’ con- 
tains a conserved Tyr residue (fig. 1). The terminal pro- 
tein of HBV is known to be linked with DNA through 
Tyr [ 16,171. In a previous publication [ 151 we proposed 
that the Tyr located in region 2 may be responsible for 
this linkage. Observation of essential structural 
homology between HDAg ’ and HBV-specific terminal 
protein suggests that HDAg’ containing a single Tyr 
residue may also be connected with nucleic acid. Fur- 
thermore, HDAg’ may compete with the terminal pro- 
tein of HBV for interaction with the polymerase and/or 
for interaction with pregenome RNA to inhibit protein 
expression encoded by this mRNA and replication of 
HDAg' 
FOL 
HBV ayw 
March 1990 
I57 190 
Fig. 4. Comparison of secondary structures predicted for the 
homologous regions of the terminal protein of HBV subtype ayw, 
POL HBV ayw, and HDAg ’ . Hollow box, o-helix. Shaded box, ,% 
strand. Wavy line, random coil. Straight line, b-turn. Distribution of 
positively and negatively charged residues in o-helices is depicted by 
+ and -, correspondingly. Triangle indicates the possible site of 
ribosome slippage. Arrow shows localization of conserved Tyr in the 
predicted nucleic acid linkage site of the protein. 
HBV virus. Thus, the HDAg’ may interfere with the 
mechanism of HBV replication. Multiplication of HBV 
is known to be inhibited by HDV [l]. 
In conclusion, it is, important to note that some 
published HDV genome sequences were found to con- 
tain a nucleotide substitution (fig. 2) leading to the ap- 
pearance of an additional stop codon in ORFS 
[6,7,13,14]. As a result of this change, Gly is 
substituted for Arg before Tyr in region 2 (fig. 1). This 
mutation may influence the activity of HDAg’ because 
Gly is part of a consensus for a nucleic acid linkage site 
[15]. If that mutation is formed during HDV infection 
and the corresponding region is the hot spot of HDV 
genome, then the modulation of the primary structure 
of HDAg ’ might regulate activity of the predicted 
protein. 
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